Quanyi Li, also known as Charlie Li received his Ph.D. in Molecular Biology in 1990 in China. Then, he received his postdoctoral trainings in UK from 1991 to 1997. His first postdoc was in molecular virology in Department of Microbiology, The University of Reading. His study was in understanding poliovirus replication and the genetic minimal requirements for a poliovirus replicon. His second postdoc was in Department of Genetics, The University of Nottingham where he studied human molecular genetics and genomics. His study had led to the discovery of TBX5 gene for Holt-Oram syndrome, a rare heart and hand defects in newborn children. In 1999, he moved to America and continued his biomedical research in University of Pennsylvania, and Columbia University for understanding human diseases using his knowledge and skills in molecular biology, genetics and genomics. His studies were published in well-known medical journals including American Journal of Pathology, BMC Medical Genetics, Circulation Research and Human Gene Therapy. The past ten years, his interests in nucleic acids – based molecular assays development has driven him working in mycoplasma detection, environmental microbiology for testing viruses in drinking water, fungi and bacteria in environments. Currently, he works on the development of molecular assays and GMP tests for adventitious viruses; Mycoplasma; bacteria and fungi in biopharmaceutical manufacturing and products
Dr. Li’s research interests are in molecular biology, genetics, genomics, virology, cell biology, pathology, biomedical research, and clinical research in general.